Effect of insulin on human aortic endothelial nitric oxide synthase

Area of Science:

• Vascular Biology
• Endocrinology
• Molecular Biology

Background:

• Insulin induces vasodilation in human vasculature.
• This vasodilatory effect is impaired in insulin-resistant states like type 2 diabetes and obesity.
• The precise molecular mechanisms underlying insulin's vasodilatory action require further elucidation.

Purpose of the Study:

• To investigate if insulin induces endothelial nitric oxide synthase (e-NOS) expression in human endothelial cells.
• To determine if this effect is dose-dependent and occurs in various human endothelial cell types.
• To explore the potential contribution of e-NOS induction to insulin's vasodilatory effects.

Main Methods:

• Human aortic endothelial cells (HAECs), human lower-limb veins, human umbilical veins (HUVECs), and microvascular endothelial cells (MVECs) were cultured.
• Cells were treated with varying concentrations of insulin (0-1,000 microU/mL) for six days.
• Western blotting was used to quantify e-NOS expression in cell homogenates.

Main Results:

• Insulin demonstrated a clear, dose-dependent induction of e-NOS expression in HAECs.
• e-NOS expression was maximal in HAECs compared to other cell types tested.
• No detectable levels of inducible NOS (i-NOS) were observed, and the effect was independent of cell proliferation.

Conclusions:

• Insulin induces a dose-dependent increase in e-NOS expression in human aortic endothelial cells.
• This mechanism may contribute to the vasodilatory properties of insulin.
• Understanding this pathway could offer insights into vascular dysfunction in metabolic diseases.